Oragenics OGEN
NYSE OGEN
$0.52 -0.01 (-2.78%)
At close: Aug 21, 2026 · 4:00 PM EDT

Oragenics (OGEN) Asset Utilization Ratio (2011 - 2023)

Oragenics' (OGEN) quarterly Asset Utilization Ratio came in at 0.01 in Q4 2023, down 29.22% YoY from 0.01 in Q4 2022, and up 27.19% on a QoQ basis from 0.0 in Q3 2023.

Oragenics (OGEN) Asset Utilization Ratio (2011 - 2023) Analysis & Trends

Oragenics (OGEN) has 7 years of Asset Utilization Ratio data on file, last reported at 0.01 in Q4 2023.

  • Quarterly Asset Utilization Ratio fell 29.22% year-over-year to 0.01 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was 0.01 (down 29.22% YoY) and the FY2023 annual result came in at 0.0, down 37.6% from the prior year.
  • Asset Utilization Ratio improved to 0.01 in Q4 2023, from 0.0 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.01 in Q2 2023 to a low of 0.0 in Q1 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 0.47
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 0.38
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 0.20
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 0.69
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 0.90
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 0.13
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 0.54
9 Royalty Pharma 27.27 Bn 26.43 Bn - 0.13
10 Oragenics 2.31 Mn 2.31 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2023 0.01
Sep 30, 2023 0.00
Jun 30, 2023 0.01
Mar 31, 2023 0.01
Dec 31, 2022 0.01
Sep 30, 2022 0.01
Jun 30, 2022 0.00
Mar 31, 2022 0.00
Sep 30, 2015 0.03
Jun 30, 2015 0.05
Mar 31, 2015 0.07
Dec 31, 2014 0.08
Sep 30, 2014 0.09
Jun 30, 2014 0.08
Mar 31, 2014 0.07
Dec 31, 2013 0.08
Sep 30, 2013 0.13
Mar 31, 2012 0.92
Dec 31, 2011 1.16
Sep 30, 2011 1.06